Clinical Trials Logo

Clinical Trial Summary

Study Title: A real-world registry of multidisciplinary collaborative diagnosis and treatment models for cardioembolic stroke Research Objectives: ① Main objective: To establish a multidisciplinary assisted diagnosis and treatment model for patients at high risk of cardioembolic stroke, manage and collect the diagnosis, treatment and prognosis data of patients. ② Secondary objective: To investigate the improvement of cardioembolic stroke, cardiovascular complex events, recurrent stroke and all-cause mortality risk, quality of life, and cardiac function between the "multidisciplinary assisted treatment model" group and the "conventional treatment model group". The routine diagnosis and treatment mode can match the patients who did not adopt the "multidisciplinary assisted diagnosis and treatment mode" in the same period. Type of design: A prospective, observational, real-world study. No fixed diagnosis and treatment plan was established in advance, and only a multidisciplinary assisted diagnosis and treatment model was established. All treatment choices were made by clinicians according to the expert consensus of relevant textbooks and clinical guidelines, and according to the patient's condition. Subjects: From September 2022 to September 2023, high-risk patients with cardioembolic stroke were collected from the Second Affiliated Hospital of Nanchang University and sub-centers of hospitals at all levels in Jiangxi Province.


Clinical Trial Description

Summary of Research Protocol: Study Title: A real-world registry of multidisciplinary collaborative diagnosis and treatment models for cardioembolic stroke Research Objectives: ① Main objective: To establish a multidisciplinary assisted diagnosis and treatment model for patients at high risk of cardioembolic stroke, manage and collect the diagnosis, treatment and prognosis data of patients. ② Secondary objective: To investigate the improvement of cardioembolic stroke, cardiovascular complex events, recurrent stroke and all-cause mortality risk, quality of life, and cardiac function between the "multidisciplinary assisted treatment model" group and the "conventional treatment model group". The routine diagnosis and treatment mode can match the patients who did not adopt the "multidisciplinary assisted diagnosis and treatment mode" in the same period. Type of design: A prospective, observational, real-world study. No fixed diagnosis and treatment plan was established in advance, and only a multidisciplinary assisted diagnosis and treatment model was established. All treatment choices were made by clinicians according to the expert consensus of relevant textbooks and clinical guidelines, and according to the patient's condition. Subjects: From September 2022 to September 2023, high-risk patients with cardioembolic stroke were collected from the Second Affiliated Hospital of Nanchang University and sub-centers of hospitals at all levels in Jiangxi Province. Multidisciplinary assisted care mode group: Patients who agreed to and accepted the recommendation of multidisciplinary assisted care mode were enrolled in the multidisciplinary assisted care mode group. These patients would undergo further stroke (primary/secondary) prevention intervention. Those who received any of the following treatments, as recommended by the standard medical procedure, were considered to have received the standard medical treatment; otherwise, they were not. 1. Surgical procedures: left atrial appendage ligation, left atrial appendage clip, valve repair or replacement, etc. 2. Medical procedures: atrial fibrillation radiofrequency ablation, valvular closure, left atrial appendage closure, etc. 3. Anticoagulant drug therapy: standardized anticoagulant drug therapy. Routine treatment mode group: Patients who did not agree to enter the multidisciplinary treatment mode were automatically entered into the routine treatment mode group. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05498909
Study type Observational [Patient Registry]
Source Second Affiliated Hospital of Nanchang University
Contact
Status Active, not recruiting
Phase
Start date August 1, 2022
Completion date June 30, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05076305 - PelvEx 4: Advanced Pelvic Malignancy and the Role of the Multi-disciplinary Team Meeting
Recruiting NCT05226182 - Visualisation of a Digital Care Pathway. N/A
Active, not recruiting NCT05987267 - Nurse-led Multidisciplinary Precision Care for Patients With Chronic Heart Failure N/A
Completed NCT03099668 - Multidisciplinary Team Care in Rheumatoid Arthritis N/A
Completed NCT05583487 - Multidisciplinary Teamwork Perceptions When Mobilizing Ventilated Neurosurgery Patients N/A
Not yet recruiting NCT05541770 - Application of MDT Clinics in Arab World
Active, not recruiting NCT05257577 - Factors Influencing Breast Cancer Resection Volumes And Their Impact on Treatment Outcome (FIBRATIO)
Completed NCT04440228 - TeamSTEPPS in School Mental Health N/A
Recruiting NCT05719870 - A Multidisciplinary Approach to Improve Adherence to Medical Recommendations in Older Adults N/A
Not yet recruiting NCT05514210 - Feasibility and Effectiveness of a Real-time Heart Team Approach in Complex CAD N/A
Not yet recruiting NCT04852250 - Centralized Tumour Board and Secondary Intervention Rate in mCRC
Completed NCT05797116 - Practice Variation in Preoperative MDT Meetings
Completed NCT03522909 - The Center for Peripartum Optimization
Completed NCT03455920 - Management of Sleep Apnea Patients by a Clinical Nurse (Supernurse) N/A